BeOne Medicines (ONC) Minority Interest (2017 - 2020)

BeOne Medicines (ONC) has 4 years of Minority Interest data on file, last reported at $9.1 million in Q3 2020.

• On a quarterly basis, Minority Interest fell 42.15% year-over-year to $9.1 million in Q3 2020; TTM through Sep 2020 was $9.1 million, a 42.15% decrease from a year earlier, with the FY2019 full-year figure at $16.2 million, up 11.8% from the prior year.
• Minority Interest for Q3 2020 stood at $9.1 million, down from $10.2 million in the prior quarter.
• Over the last five years, Minority Interest for ONC reached as high as $17.4 million in Q2 2019 and fell as low as $9.1 million in Q3 2020.
• Historically, Minority Interest has averaged $14.0 million across 4 years, with a median of $14.4 million in 2017.
• Across the five-year window, Minority Interest increased 29.07% in 2019 and tumbled 42.15% in 2020, its largest moves.
• Year by year, Minority Interest stood at $14.4 million in 2017, then climbed by 0.16% to $14.4 million in 2018, then increased by 11.8% to $16.2 million in 2019, then sank by 43.55% to $9.1 million in 2020.
• Per Business Quant data, the three most recent Minority Interest figures were $9.1 million in Q3 2020, $10.2 million in Q2 2020, and $14.8 million in Q1 2020.